Dr Richard Blennerhassett

Dr Richard Blennerhassett

Clinical and Laboratory Haematologist

Dr Richard Blennerhassett holds dual qualifications as a clinical and laboratory haematologist with fellowships from both the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia. He specialises in all aspects of malignant and non-malignant haematology.

He was awarded 1st class honours from the Sydney University Medical School. He pursued post-graduate Haematology training at Westmead and Royal North Shore Hospital. There he gained expertise managing leukaemia and lymphoma, bone marrow / stem cell transplant and cellular therapies, thrombosis and haemostasis, as well as pregnancy-related haematologic conditions.

Subsequently, he undertook a Fellowship in Stem Cell Transplant at St Vincent’s Hospital, Sydney, where he developed further expertise in bone marrow transplantation.

Dr Blennerhassett maintains a strong interest in the education of junior medical officers and medical students, with a conjoint lecturer position held at Sydney University since 2012.

Dr Blennerhassett is passionate about providing you with high quality, evidence-based care. He remains up to date with recent advances in Haematology via several affiliations with national and international professional associations and is an active contributor to the medical field with publications across a wide array of topics within the medical literature.

Current Appointments

Central Coast Local Health District Gosford and Wyong Hospital

Gosford Private Hospital

Tuggerah Lakes Private Hospital

Berkeley Vale Private Hospital

Brisbane Waters Private Hospital

Specialist Qualifications and Affiliations

Bachelor of Medicine

Bachelor of Applied Science (Hons)

Fellow of The Royal Australasian College of Physicians

Fellow of The Royal College of Pathologists of Australasia


  1. Blennerhassett R, Lillo P, Halliday G.M, Hodges J.R, Kril, J.J. Distribution of pathology in frontal variant Alzheimer’s disease. Journal of Alzheimer's Disease. 2014, 39(1):63-70.

  2. O'Day R, Walton R, Blennerhassett R, Gillies M, Barthelmes D. Reporting of harms by randomised controlled trials in ophthalmology. British Journal of Ophthalmology. 2014, 98(8) 1003-1008.

  3. Blennerhassett R, Favaloro E, Pasalic L. Novel (oral) anticoagulant challenges in surgery. Seminars in Thrombosis & Hemostasis. 2017, 43(7):706-715.

  4. Blennerhassett R, McCaughan G, Tegg, E. An unexpected diagnosis: leukaemic presentation of blastic plasmacytoid dendritic cell neoplasm with massive splenomegaly. Pathology. 2018, 50(7):773-75.

  5. Blennerhassett R, Sudini L, Gottlieb, D, Bhattacharyya A. Post allogeneic transplant Evans syndrome successfully treated with daratumumab. British Journal of Haematology. 2019, 187(2):e48-51

  6. Blennerhassett R, Favaloro E, Pasalic L. Coagulation studies: achieving the right mix in a large laboratory network. Pathology. 2019, 51(7):718-722

  7. Blennerhassett R, Curnow J, Pasalic L. Immune-mediated thrombotic thrombocytopenic purpura: a narrative review of diagnosis and treatment in adults. Seminars in Thrombosis & Haemostasis. 2020, 46(3):289-301.

  8. Blennerhassett R, Kwan J, Coyle L, Wong K, Greenwood M. Adult B‐ and T‐lymphoblastic lymphoma treated with a paediatric acute lymphoblastic leukaemia regimen have excellent outcomes—a short report from two Sydney centres. British Journal of Haematology. 2020, 191(2):e58-60

  9. Blennerhassett R, Purtill D, Hamad N. Ongoing Cryopreservation Challenges in the COVID Era – Cryopreserved Grafts for Severe Aplastic Anemia. Biology of Blood and Marrow. Transplantation. In Press.